Intravenous ascorbic acid
Intravenous ascorbic acid is a method of administering vitamin C directly into the bloodstream through an intravenous (IV) infusion. This method is used in various medical treatments and is believed to have several therapeutic benefits.
Medical Uses[edit | edit source]
Intravenous ascorbic acid is primarily used in the treatment of severe vitamin C deficiency, known as scurvy. It is also used as an adjunct therapy in the treatment of certain types of cancer, where it is believed to enhance the effects of chemotherapy and reduce the side effects of conventional cancer treatments. Additionally, IV ascorbic acid is used in the management of sepsis and severe infections due to its potential to modulate the immune system and reduce inflammation.
Mechanism of Action[edit | edit source]
Ascorbic acid, also known as ascorbate, is a potent antioxidant that helps to neutralize free radicals in the body. When administered intravenously, it achieves much higher concentrations in the blood compared to oral administration. These high concentrations are thought to exert pro-oxidant effects that can be toxic to cancer cells while sparing normal cells. Additionally, ascorbic acid plays a crucial role in the synthesis of collagen, neurotransmitters, and carnitine, and it enhances the absorption of iron from the diet.
Administration[edit | edit source]
Intravenous ascorbic acid is typically administered in a clinical setting by a healthcare professional. The dosage and frequency of administration depend on the condition being treated and the patient's overall health status. It is usually given in high doses, ranging from 10 grams to 100 grams per infusion, and the duration of the infusion can vary from 30 minutes to several hours.
Side Effects[edit | edit source]
While intravenous ascorbic acid is generally well-tolerated, it can cause side effects in some individuals. Common side effects include nausea, headache, and dizziness. Rare but serious side effects can include kidney stones and hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency). It is important for patients to be screened for G6PD deficiency before receiving high-dose IV ascorbic acid.
Research and Controversy[edit | edit source]
The use of intravenous ascorbic acid in the treatment of cancer and other serious conditions is a topic of ongoing research and debate. Some studies suggest that it may improve the quality of life and survival rates in cancer patients, while others have found no significant benefit. The National Institutes of Health and other research organizations continue to investigate the potential therapeutic uses of high-dose vitamin C.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD